CYTK
CYTK
NASDAQ · Biotechnology

Cytokinetics Inc

$67.59
+0.03 (+0.04%)
As of Sep 22, 9:48 PM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 25 89%
Hold 3 11%
Sell 0 0%
Price Target
Analyst Price Target +18.1% upside
Low Target $53.35
Average Target $79.81
High Target $115.71
Current Price $67.59
Current
$67.59
Target
$79.81
$53.35 $79.81 avg $115.71
Scenario Analysis
Bear Case
$53.35
-21.1%
Low target
Base Case
$79.81
+18.1%
Avg target
Bull Case
$115.71
+71.2%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$88.31
-23.5% from high
52-Week Low
$47.22
+43.1% from low
50-Day SMA
$63.59
+6.3% vs SMA
200-Day SMA
$49.97
+35.3% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$79.81
-9.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%